3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
11
Sarcoma
6
Neoplasms
6
Lymphoma, Mantle-Cell
6
Prostatic Neoplasms
5
Lymphoma, Non-Hodgkin
5
Rhabdomyosarcoma
4
Neoplasm Metastasis
4
Kidney Neoplasms
4
Gliosarcoma
4
Glioblastoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Endometrial Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Liposarcoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Glioma
2
Fallopian Tube Neoplasms
2
Carcinoma, Hepatocellular
2
Interventions
fludarabine phosphate
15
Cyclophosphamide
13
Whole-Body Irradiation
12
Peripheral Blood Stem Cell Transplantation
12
Tacrolimus
10
Etoposide
10
Rituximab
8
Mycophenolic Acid
8
Methotrexate
6
Melphalan
6
Cyclosporine
6
Busulfan
6
Antilymphocyte Serum
6
Vorinostat
4
Sirolimus
4
Prednisone
4
Lenalidomide
4
Immunohistochemistry
4
Gene Expression Profiling
4
Carboplatin
4
Vincristine
3
Microarray Analysis
3
Gemcitabine
3
Everolimus
3
Doxorubicin
3
Dexamethasone
3
Brentuximab Vedotin
3
Alemtuzumab
3
10-propargyl-10-deazaaminopterin
3
thymoglobulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Immunoblastic Lymphadenopathy
×
temsirolimus
×
Clear all
No trials found.